Risk factors for peritoneal dialysis withdrawal due to peritoneal dialysis-related peritonitis in King Narai Hospital.
Keywords:
Chronic kidney disease patients, Peritoneal dialysis, Peritonitis, Treatment failureAbstract
This study was retrospective case-control study design to compare the demographic and clinical characteristics of patients with peritonitis between two groups: those who successfully underwent continuous ambulatory peritoneal dialysis and those who experienced treatment failure. The study aimed to identify factors associated with treatment failure. The sample comprised 276 patients diagnosed with end-stage renal disease who underwent peritoneal dialysis and developed peritonitis between October 1, 2018, and September 30, 2022. Data were collected using a researcher-developed data recording form and analyzed using descriptive statistics, chi-square tests, t-tests, and logistic regression analysis.
Results: Among the 276 patients included in the study, 13% concurrent catheter-related peritoneal dialysis peritonitis. The most common causative organism was Staphylococcus coagulase-negative (26.8%). Factors significantly associated with treatment failure included the frequency of infection, fungal peritonitis, diabetes mellitus, hemoglobin levels < 10 g/dL, and Kt/V < 1.7 (p < 0.05).
References
Bunnag S, Thanakitcharu P, Krairittichai U, Jirajan B, Meenune W, Kanjanapanth C. Risk factors of infectious peritonitis of CAPD patients in Rajavithi Hospital. J Med Assoc Thail 2011; 94 (Suppl 4): S37-43.
Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999; 26(3-4): 259-65.
Pakorn Tungkasereerak. The Prognostic Factors of Recurrent Peritonitis in CAPD Patients. Srinagarind Med J 2017; 32(6): 519-23.
Nadeau-Fredette AC and Bargman JM. Characteristics and outcomes of fungal peritonitis in a modern North American cohort. Perit Dial Int 2015; 35(1): 78–84.
Chang TI, Kim HW, Park JT, et al. Early catheter removal improves patient survival in peritoneal dialysis patients with fungal peritonitis: results of ninety-four episodes of fungal peritonitis at a single center. PeritDial Int 2011; 31(1): 60–66.
Li PK, Chow KM, Cho Y, Fan S, Figueiredo AE, Harris T, Kanjanabuch T, Kim YL, Madero M, Malyszko J, Mehrotra R, Okpechi IG, Perl J, Piraino B, Runnegar N, Teitelbaum I, Wong JK, Yu X, Johnson DW. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022 Mar;42(2):110-153.
Goldie SJ, Kiernan-Tridle L, Torres C, et al. Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am J Kidney Dis 1996; 28(1): 86–91.
Wang AY, Yu AW, Li PK, et al. Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center. Am J Kidney Dis 2000; 36(6): 1183–1192.
Hassoun AA, Coomer RW and Mendez-Vigo L. Intraperitoneal daptomycin used to successfully treat vancomycinresistant enterococcus peritonitis. Perit Dial Int 2009; 29(6): 671–673.
Nochaiwong, S., Ruengorn, C., Koyratkoson, K. et al. A Clinical Risk Prediction Tool for Peritonitis-Associated Treatment Failure in Peritoneal Dialysis Patients. Sci Rep 8, 14797 (2018).
Chow KM, Szeto CC, Cheung KK, et al. Predictive value of dialysate cell counts in peritonitis complicating peritoneal dialysis. Clin J Am Soc Nephrol 2006; 1(4): 768–773.
Lo WK, Ho YW, Li CS, Wong KS, Chan TM, Yu AW, Ng FS, Cheng IK. Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int. 2003 Aug;64(2):649-56. doi: 10.1046/j.1523-1755.2003.00098.x. PMID: 12846762.
